Cargando…
CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
Gastric cancer (GC) is one of the most commonly diagnosed malignancies and, unfortunately, still has a high mortality rate. Recent research points to CAR-T immunotherapy as a promising treatment for this disease. Using genetically engineered T cells designed to target a previously selected antigen,...
Autores principales: | Bębnowska, Dominika, Grywalska, Ewelina, Niedźwiedzka-Rystwej, Paulina, Sosnowska-Pasiarska, Barbara, Smok-Kalwat, Jolanta, Pasiarski, Marcin, Góźdź, Stanisław, Roliński, Jacek, Polkowski, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355670/ https://www.ncbi.nlm.nih.gov/pubmed/32560392 http://dx.doi.org/10.3390/jcm9061894 |
Ejemplares similares
-
Toll-like Receptor 2 as a Marker Molecule of Advanced Ovarian Cancer
por: Sobstyl, Małgorzata, et al.
Publicado: (2021) -
Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
por: Grywalska, Ewelina, et al.
Publicado: (2020) -
Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
por: Grywalska, Ewelina, et al.
Publicado: (2020) -
Immunological Prognostic Factors in Multiple Myeloma
por: Bębnowska, Dominika, et al.
Publicado: (2021) -
Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?
por: Grywalska, Ewelina, et al.
Publicado: (2022)